SAKK 21/12: A stratified, multicenter phase II trial of transdermal CR1447 in endocrine responsive-HER2 negative and triple negative-androgen receptor positive metastatic or locally advanced breast cancer

Locally Advanced ◽

Advanced Breast ◽

Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.876 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 876-876 ◽

Cited By ~ 1

Author(s):

S. X. Franco ◽

A. Perez ◽

C. Frankel ◽

E. Tan-Chiu ◽

L. Schwartzberg ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Preliminary Results ◽

P91 Gemcitabine, epirubicin, and docetaxel (GED) asneoadjuvant therapy. Updated results from a multicenter phase II trial in locally advanced breast cancer

The Breast ◽

10.1016/s0960-9776(05)80127-4 ◽

2005 ◽

Vol 14 ◽

pp. S41

Author(s):

D. Yardley ◽

P. Whitworth ◽

F. Greco ◽

L. Dunbar ◽

H. Burris ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer

Journal of Breast Cancer ◽

10.4048/jbc.2017.20.4.340 ◽

2017 ◽

Vol 20 (4) ◽

pp. 340

Author(s):

Ye Won Jeon ◽

Tae Hyun Kim ◽

Hyun Jo Youn ◽

Sehwan Han ◽

Yongsik Jung ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.029 ◽

2008 ◽

Vol 8 (3) ◽

pp. 257-263 ◽

Cited By ~ 6

Author(s):

John T. Hamm ◽

John W. Wilson ◽

Priya Rastogi ◽

Barry C. Lembersky ◽

George C. Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced ◽

OT2-01-03: Eribulin in Women with Locally Advanced Breast Cancer Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy: A Sarah Cannon Research Institute Phase II Trial.

10.1158/0008-5472.sabcs11-ot2-01-03 ◽

2011 ◽

Author(s):

DA Yardley ◽

NW Peacock ◽

JD Hainsworth ◽

III HA Burris

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Pathologic Complete Response ◽

Complete Response ◽

Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.789 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 789-789

Author(s):

S. Karmarkar ◽

D. Jones ◽

S. Hatch ◽

F. Klementich ◽

K. Ansari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80207-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S69-S70

Author(s):

G Fried

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.789 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 789-789

Author(s):

S. Karmarkar ◽

D. Jones ◽

S. Hatch ◽

F. Klementich ◽

K. Ansari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.031 ◽

2010 ◽

Vol 10 (3) ◽

pp. 230-237 ◽

Cited By ~ 8

Author(s):

Helen Gogas ◽

Dimitrios Pectasides ◽

Ioannis Kostopoulos ◽

Evangelos Lianos ◽

Dimosthenis Skarlos ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Oncology Group

Abstract P1-11-08: A Multicenter Prospective Phase II Trial of Neo-Adjuvant (FEC 100)/Cisplatin-Docetaxel with or without Trastuzumab in Locally Advanced Breast Cancer. Gulf Oncology Research Group (G0RG-001)

10.1158/0008-5472.sabcs10-p1-11-08 ◽

2010 ◽

Author(s):

TA AL-Tweigeri ◽

AA Alsayed ◽

MM Ibrahim ◽

WM Ashaur ◽

HN Jaafar ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Oncology Research ◽

Prospective Phase